ClinicalTrials.govpublic full text
Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer
carcinoma, large cell, carcinoma, non-small-cell lung, carcinoma, squamous cell, carcinoma, adenosquamous cell, igr-1r, non small cell lung cancer, cp-751, 871, figitumumab, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 867349
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.